Global clinical trial shows improved survival rates for common childhood leukemia

Just days before his fourth birthday, Santiago was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL), the most common cancer in children. He began chemotherapy the next day, and the outlook was promising—disease-free survival rates for B-ALL are among the highest for pediatric cancers, at 80 to 85%. However, limited progress has been made over the last 15 years, and relapsed B-ALL remains a leading cause of cancer death among children.

Facebook Comments